4//SEC Filing
Facchini Peter J. 4
Accession 0001493152-23-002452
CIK 0000890821other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:30 PM ET
Size
7.5 KB
Accession
0001493152-23-002452
Insider Transaction Report
Form 4
Facchini Peter J.
CHIEF INNOVATION OFFICER
Transactions
- Award
Common Stock
2021-10-13+1,021→ 13,356 total - Award
Common Stock
2021-10-13+10,500→ 23,856 total
Footnotes (3)
- [F1]The reporting person received the restricted stock units (RSUs) as a one-time signing bonus upon the commencement of the reporting person's employment with the Company. 50% of the RSUs shall vest over 2 years in equal annual installments, with the first tranche to vest on September 16, 2022. 50% of the RSUs shall vest over 2 years in equal annual installments, if the Company's average VWAP exceeds 110% and 120% of $158.925, respectively.
- [F2]Includes 10,633 shares previously held through the Facchini 2020 Family Trust, which were distributed to the reporting person and are now owned directly.
- [F3]50% of the RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on September 16, 2022. 50% of the RSUs shall vest in 3 approximately equal tranches on each of December 31, 2022, 2023 and 2024, if the Company's average VWAP (calculated as the average over the fourth calendar quarter of each of 2022, 2023 and 2024, as applicable, of the daily volume weighted average price of a share of common stock), exceeds $119.00, $130.50 and $143.50, respectively.
Documents
Issuer
Enveric Biosciences, Inc.
CIK 0000890821
Entity typeother
Related Parties
1- filerCIK 0001883966
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 4:30 PM ET
- Size
- 7.5 KB